Drug comparisons
Eptinezumab vs Galcanezumab
Eptinezumab (Vyepti) vs Galcanezumab (Emgality): CGRP mAb for migraine prevention. Eptinezumab IV q3m, Galcanezumab SC monthly/q3m. Similar efficacy, diff dosing.
No comparison dimensions are available for this page.
Clinical context
Patients with migraine who are considering CGRP monoclonal antibody preventive treatments.
Bottom line
Both Eptinezumab and Galcanezumab are effective options for migraine prevention, with selection based on dosing preferences and individual factors.
All medication comparisons